Back to top

rating-upgrade: Archive

Zacks Equity Research

Andritz (ADRZY) Upgraded to Strong Buy: Here's Why

Andritz (ADRZY) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

ADRZYPositive Net Change

Zacks Equity Research

All You Need to Know About SkyWest (SKYW) Rating Upgrade to Buy

SkyWest (SKYW) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

SKYWPositive Net Change

Zacks Equity Research

Stagwell (STGW) Moves to Buy: Rationale Behind the Upgrade

Stagwell (STGW) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

STGWNegative Net Change

Zacks Equity Research

Puma Biotech (PBYI) Upgraded to Strong Buy: Here's What You Should Know

Puma Biotech (PBYI) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

PBYIPositive Net Change

Zacks Equity Research

All You Need to Know About Carpenter (CRS) Rating Upgrade to Buy

Carpenter (CRS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

CRSNegative Net Change

Zacks Equity Research

All You Need to Know About Five9 (FIVN) Rating Upgrade to Buy

Five9 (FIVN) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

FIVNNegative Net Change

Zacks Equity Research

All You Need to Know About Ponce Financial (PDLB) Rating Upgrade to Strong Buy

Ponce Financial (PDLB) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

PDLBNegative Net Change

Zacks Equity Research

All You Need to Know About Humacyte, Inc. (HUMA) Rating Upgrade to Buy

Humacyte, Inc. (HUMA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

HUMAPositive Net Change

Zacks Equity Research

TaskUs (TASK) Moves to Buy: Rationale Behind the Upgrade

TaskUs (TASK) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

TASKNegative Net Change

Zacks Equity Research

Spotify (SPOT) Upgraded to Strong Buy: What Does It Mean for the Stock?

Spotify (SPOT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

SPOTPositive Net Change

Zacks Equity Research

AdaptHealth (AHCO) Upgraded to Buy: Here's What You Should Know

AdaptHealth (AHCO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

AHCOPositive Net Change

Zacks Equity Research

Astellas Pharma (ALPMY) Upgraded to Strong Buy: What Does It Mean for the Stock?

Astellas Pharma (ALPMY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

ALPMYNegative Net Change

Zacks Equity Research

FirstCash (FCFS) Upgraded to Buy: What Does It Mean for the Stock?

FirstCash (FCFS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

FCFSPositive Net Change

Zacks Equity Research

Middlefield Banc (MBCN) Upgraded to Strong Buy: Here's Why

Middlefield Banc (MBCN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

MBCNNegative Net Change

Zacks Equity Research

CyberArk (CYBR) Upgraded to Buy: Here's Why

CyberArk (CYBR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

CYBRNegative Net Change

Zacks Equity Research

GENEDX HOLDINGS (WGS) Upgraded to Buy: Here's Why

GENEDX HOLDINGS (WGS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

WGSNegative Net Change

Zacks Equity Research

All You Need to Know About Alignment Healthcare (ALHC) Rating Upgrade to Buy

Alignment Healthcare (ALHC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

ALHCPositive Net Change

Zacks Equity Research

1st Source (SRCE) Upgraded to Buy: Here's Why

1st Source (SRCE) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

SRCENegative Net Change

Zacks Equity Research

First Financial (FFBC) Upgraded to Buy: Here's What You Should Know

First Financial (FFBC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

FFBCNegative Net Change

Zacks Equity Research

TripAdvisor (TRIP) Upgraded to Buy: What Does It Mean for the Stock?

TripAdvisor (TRIP) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

TRIPNegative Net Change

Zacks Equity Research

Esquire Financial (ESQ) Upgraded to Buy: Here's Why

Esquire Financial (ESQ) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

ESQNegative Net Change

Zacks Equity Research

Adidas (ADDYY) Upgraded to Buy: What Does It Mean for the Stock?

Adidas (ADDYY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

ADDYYNegative Net Change

Zacks Equity Research

PAVmed (PAVM) Upgraded to Buy: Here's What You Should Know

PAVmed (PAVM) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

PAVMNegative Net Change

Zacks Equity Research

What Makes Supernus (SUPN) a New Buy Stock

Supernus (SUPN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

SUPNNegative Net Change

Zacks Equity Research

All You Need to Know About South Plains Financial (SPFI) Rating Upgrade to Strong Buy

South Plains Financial (SPFI) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

SPFINegative Net Change